U-Neuron Biomedical

U-Neuron Biomedical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of U-Neuron Biomedical (6973.TWO) as of Oct 11, 2026 is -68.22 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -89.05 M TWD — a change of -23.39% (higher).

EBITDA

-68.22 MTWD

YoY

-23.39%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of U-Neuron Biomedical is 2024 -68.22 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of U-Neuron Biomedical was 2023 -89.05 M TWD. It decreases by -23.39% higher compared to the previous year.

The U-Neuron Biomedical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
-13.94 M TWD
Jan 1, 2022
-42.39 M TWD
Jan 1, 2023
-89.05 M TWD
Jan 1, 2024
-68.22 M TWD
The U-Neuron Biomedical EBITDA history
YEAREBITDAYoY
-68.22 MTWD-23.39%
-89.05 MTWD+110.08%
-42.39 MTWD+204.05%
-13.94 MTWD—
Access this data via the Eulerpool API
Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of U-Neuron Biomedical is -68.22 M TWD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of U-Neuron Biomedical changed from -89.05 M TWD to -68.22 M TWD, representing a -23.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s U-Neuron Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — U-Neuron Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — U-Neuron Biomedical